BACKGROUND--DDD pacing has been advocated as an effective treatment for drug
refractory obstructive hypertrophic cardiomyopathy. This study reports the outcome of pacing …

Patients with hypertrophic cardiomyopathy frequently complain of chest pain during daily
activities. ST-segment depression is described in association with sudden death and pacing …

Historical Background Sudden death is a well-recognized complication in patients with
HCM. 3-6 Retrospective reviews do not suggest thatsymptomatic therapy (p-blockers …

Objectives. This study aimed to assess autonomic nervous system activity in patients with
hypertrophic cardiomyopathy. Background. Patients with hypertrophic cardiomyopathy are …

OBJECTIVE: To investigate the efficacy of internal cardioversion using low energy shocks
delivered with a biatrial electrode configuration in chronic atrial fibrillation resistant to …

This study aims to assess the dynamics of the QT interval in patients with hypertrophic
cardiomyopathy (HCM). Three consecutive QT intervals and the preceding RR intervals …

Adenosine has been proposed as a useful diagnostic agent in patients with narrow complex
regular tachycardia of uncertain origin. Its effects are usually transient owing to its extremely …

One of the principle aims in the assessment of the patient with hypertrophic cardiomyopathy
is assessment of risk for sudden cardiac death. Conventional risk stratification is reviewed …

A 31 year old man presented with an anterior myocardial infarction. He had a history of
recurrent gastrointestinal bleeding of obscure cause since childhood and peripheral …

Atrial fibrillation is the commonest arrhythmia observed in hypertrophic cardiomyopathy, and
is associated with an acute deterioration in symptoms. Digoxin is the drug of choice in …